OWL: Continuing Medical Education

ME M�ller Foundation - Spain

Matias — 2003-03-14 21:00:29 GMT

The Maurice E. M�ller Foundation-Espa�a is carrying out a program for continuing education in Orthopaedic Surgery. We deliver Post-graduate courses accredited by the Universitat de Barcelona and the Universitat Autonoma de Barcelona.

Orthogate Event Calendar

Christian Veillette — 2002-04-19 21:00:29 GMT

Orthogate Event Calendar. Contains important dates for Meetings, Symposia, Conferences and other CME Events.

Edinburgh International Trauma Symposium and Instructional Trauma Courses

Mrs C Hajducka, OOPD, Royal Infirmary — 2003-03-14 21:00:29 GMT

International Trauma Symposium - Yearly in August. The Edinburgh International Trauma Symposium was established in 1987 with the aim of disseminating and discussing current philosophies of orthopaedic trauma management. Different aspects of orthopaedic trauma and its management are discussed each year with the emphasis being on new ideas and philosophies. The meeting has grown in size over the years and now attracts 200�300 participants from over 35 different countries.

Managment of Open Fractures

2005-08-29 21:00:29 GMT

AAOS online CME course 2003 Editor Marc Swiontkowski

2000 ACL Reconstruction Gender Issues in ACL Injury, and Meniscus Repair Medscape CME

Don Johnson — 2010-06-09 21:00:29 GMT

Knee Injury: ACL Reconstruction, Gender Issues in ACL Injury, and Meniscus Repair Don Johnson, MD
Published: 03/17/2000; Updated: 03/15/2000
In the past, orthopaedic surgeons have relied on the classic article by Daniel and colleagues[1] in counseling patients on what to expect after anterior cruciate ligament (ACL) surgery. Daniel and colleagues reported that patients who underwent ACL reconstruction sustained degenerative changes on x-rays, a pessimistic outcome thought to be due to the types of surgery performed and the rehabilitation completed. Two papers presented today update those findings by offering long-term follow-up of ACL reconstruction using patellar tendon grafts and relate the results to the status of the meniscus and articular surface at the time of operation.

2001 Diagnosis and Treatment for Osteoporosis- Current Status and Expectations for the New Millennium

Christian Veillette — 2002-10-11 21:00:29 GMT

Diagnosis and Treatment for Osteoporosis: Current Status and Expectations for the New Millennium Author: Thomas J. Schnitzer, MD, PhD Release Date: December 18, 2001; Valid for credit through December 18, 2002

2003 Osteoporosis- Consider the Outcomes

Christian Veillette — 2002-10-11 21:00:29 GMT

Osteoporosis: Consider the Outcomes Authors: Richard Eastell, MD, FRCP, FRCPath, FMedSci; Nelson B. Watts, MD Medical Writer: Joyce Sherman Kelly, PhD Release Date: March 8, 2002; Valid for credit through March 8, 2003

2007 ACL reconstruction failure and revisions

Sheila Strover — 2008-06-09 21:00:29 GMT

The kNEEguru website presents a new course by Dr Frank Noyes on the reasons for ACL graft failure and the pitfalls of reconstruction surgery. Aimed at the consumer, but at a good level for family practitioners, the rehabilitation team, nurses and medical students. [Free]

2007 Algorithm May Help Predict 5-Year Risk for Hip Fracture in Women Medscape CME

Laurie Barclay, MD — 2008-03-19 21:00:29 GMT

December 3, 2007 � An algorithm composed of 11 readily available clinical variables offers a simple means to stratify the 5-year risk of hip fracture in postmenopausal women, according to the results of a study published in the November 28 issue of the Journal of the American Medical Association.
There were 11 factors associated with the increased risk for hip fracture within 5 years: age, self-reported health, weight, height, race or ethnicity, self-reported physical activity, history of fracture after age 54 years, parental hip fracture, current smoking, current use of corticosteroids, and treated diabetes.

2007 The Role of Imaging in the Management of Rheumatoid Arthritis

Troum et al — 2008-07-23 21:00:29 GMT

What does this mean for my patients? Upon completing this activity, you should be able to differentiate between the van der Heijde-modified Sharp, modified Genant, and Larsen scoring systems and describe how they are utilized in measuring joint alterations in RA patients, identify 3 different imaging techniques used in assessing RA severity and the benefits and limitations of each, evaluate magnetic resonance imaging, ultrasonography, and x-ray data for joint alterations due to RA, and more.
Authors - Orrin M. Troum, MD John V. Crues, III, MD Sergio Schwartzman, MD

2008 Bone Health in Cancer Care

Gralow — 2009-05-27 21:00:29 GMT

A presentation from the NCCN 14th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care held in Hollywood, Florida. Dr Judy Gralow 2008
The agenda and topics for our task force meeting that are currently being put into a draft report were the screening and detection of osteoporosis, treatment options for osteoporosis, the impact of chemotherapy-induced ovarian failure on bone health, aromatase inhibitor bone loss, and management of bone health in prostate cancer. We incorporated a new section on the role of adjuvant bisphosphonates to reduce recurrence. We talked about the pathophysiology of bone metastases, the treatment of bone metastasis, imaging of bone metastasis, and then surgical and radiation treatment of bone metastasis.

2008 Comparative Effectiveness of Treatments To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis Medscape CME

Not Available — 2009-09-28 21:00:29 GMT

Agency for Healthcare Research and Quality (AHRQ) Executive Summary
The goal of this activity is to education health professionals about the latest evidence for comparing treatments for osteoporosis.
The summary addresses the following questions
Key Question 1. What are the comparative benefits in fracture reduction among and also within the following treatments for low bone density:
Bisphosphonate medications, specifically alendronate, risedronate, etidronate, ibandronate, pamidronate, and zoledronic acid.
Calcitonin.
Calcium.
Estrogen for women.
Parathyroid hormone (PTH).
Selective estrogen receptor modulators (SERMs), specifically raloxifene and tamoxifen.
Testosterone for men.
Vitamin D.
Combinations of above.
Exercise in comparison to above agents.
Key Question 2. How does fracture reduction resulting from treatments vary between individuals with different risks for fracture as determined by bone mineral density (borderline/low/severe), prior fractures (prevention vs. treatment), age, gender, glucocorticoid use, and other factors (e.g., community dwelling vs. institutionalized, vitamin D deficient vs. not)?
Key Question 3. What are the adherence and persistence to medications for the treatment and prevention of osteoporosis, the factors that affect adherence and persistence, and the effects of adherence and persistence on the risk of fractures?
Key Question 4. What are the short- and long-term harms (adverse effects) of the above therapies, and do these vary by any specific subpopulations?

2009 A 31-Year-Old Woman With a Painful Right Wrist Medscape CME

Djamil Fertikh, MD — 2009-05-27 21:00:29 GMT

Case Presentation of a patient with De Quervain's Tenosynovitis; account of the condition, MR imaging and treatment options

2009 A Multidisciplinary Approach to RA Patient Care Medscape CME

Ruffing et al — 2009-09-28 21:00:29 GMT

The goal of this panel discussion is to highlight optimal approaches to Rheumatoid Arthritis disease management involving a multidisciplinary team, to identify barriers that may lead to lack of confidence in optimally managing patients with RA, and to identify strategies to overcome such barriers.
Victoria Ruffing, RN, CCRP; Jon T. Giles, MD, MPH; Nicole M. Furfaro, MSN, ARNP MedscapeCME Rheumatology � 2009

2009 Approaches to the Targeting of Treatment for Osteoporosis Medscape CME

Kanis et al — 2009-08-17 21:00:29 GMT

Fractures are a clinical consequence of osteoporosis, and represent a major cause of morbidity and mortality worldwide. Several treatments have been shown to decrease the risk of fracture, but problems arise in identifying individuals at high fracture risk so that treatments can be effectively targeted. The case for widespread population screening using bone mineral density testing is weak, as these tests lack sensitivity. Case-finding algorithms are available in many countries, but differ markedly in their approaches. Recent developments in fracture risk assessment include the availability of the FRAX� (WHO Collaborating Center for Bone Metabolic Disease, Sheffield, UK) tool, which integrates the weight of clinical risk factors for fracture risk with or without information on bone mineral density, and computes the 10-year probability of fracture. The tool increases sensitivity without trading specificity, and is now being used in the reappraisal of clinical guidelines.
John A. Kanis, MD; Eugene V. McCloskey, MD; Helena Johansson, BSc; Anders Oden, PhD Nat Rev Rheumatol CME. 2009;5(8):425-431.